Daiken Medical Co., Ltd.
Stock Price Chart
2026/07/31 UpdatedPrice Trend
2026/07/31 UpdatedPrice & Trading Details
2026/07/31 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/07/01Dividend History
Updated 2026/07/26| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥11 | -52.2% |
| 2025 | ¥23 | +9.5% |
| 2024 | ¥21 | +5.0% |
| 2023 | ¥20 | 0.0% |
| 2022 | ¥20 | - |
Financial Performance
2026/07/26 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥9,137M | ¥9,750M | ¥9,952M | ¥10,291M |
| Gross Profit | ¥3,530M | ¥3,982M | ¥4,097M | ¥3,952M |
| Operating Income | ¥1,054M | ¥1,443M | ¥1,512M | ¥1,278M |
| Pretax Income | ¥1,029M | ¥1,441M | ¥1,518M | ¥1,258M |
| Net Income | ¥712M | ¥989M | ¥1,098M | ¥923M |
| EPS | ¥24.79 | ¥34.41 | ¥38.21 | ¥32.12 |
| Operating Margin | 11.54% | 14.80% | 15.19% | 12.41% |
| Balance Sheet | ||||
| Total Assets | ¥11,013M | ¥11,006M | ¥11,181M | ¥11,367M |
| Total Equity | ¥6,597M | ¥7,022M | ¥7,516M | ¥7,777M |
| Total Liabilities | ¥4,416M | ¥3,984M | ¥3,665M | ¥3,589M |
| Cash | ¥2,516M | ¥2,739M | ¥2,996M | ¥2,778M |
| Interest-bearing Debt | ¥2,720M | ¥2,118M | ¥2,026M | ¥2,250M |
| Equity Ratio | 59.90% | 63.80% | 67.22% | 68.42% |
| D/E Ratio | 0.41 | 0.30 | 0.27 | 0.29 |
| Cash Flow | ||||
| Operating CF | ¥989M | ¥1,556M | ¥1,121M | ¥568M |
| Investing CF | -¥211M | -¥169M | -¥168M | -¥330M |
| Financing CF | -¥781M | -¥1,164M | -¥696M | -¥455M |
| Free CF | ¥790M | ¥1,387M | ¥953M | ¥240M |
| Efficiency | ||||
| ROE | 10.79% | 14.08% | 14.60% | 11.86% |
| ROA | 6.47% | 8.98% | 9.82% | 8.12% |
Latest IR Information
-
2027 Q1 Financial Results | Revenue: ¥2,439 million (YoY -2.3%)
Daken Medical Instruments' consolidated results for the first quarter of fiscal year 2027 (ending March 2027) showed revenue of ¥2,439 million (down 2.3% YoY), operating income of ¥214 million (down 23.9%), and net income of ¥167 million (down 22.3%). Despite...
Read more -
Status of MDR Application Approval for the European Expansion of Quadec Amy PCA (Progress of Disclosure Items)
Report on MDR certification status for the European rollout of QuDEC Aimé PCA, upcoming schedule, and regulatory filings outside Europe. Although the timing of MDR certification is undecided, we plan to file within this fiscal year. The impact on this...
Read more
Latest News (5 items)
Company Information
About
Daiken Medical Co., Ltd. engages in the manufacture and distribution of medical devices and equipment in Japan and internationally. The company offers suction devices; balloon type and syrinjector disposable infusion pumps; endobronchial blocker tubes; and wet disinfectant mats. It also involved in trading of medical equipment. It sells its products under the COOPDECH brand name. Daiken Medical Co., Ltd. was incorporated in 1968 and is headquartered in Izumi, Japan.
